Discontinued — last reported Q4 '23
KKR & Co. Equity method investment, maximum exposure to loss decreased by 2.5% to $19.70M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 6.2%, from $21.00M to $19.70M. Over 2 years (FY 2021 to FY 2023), Equity method investment, maximum exposure to loss shows a downward trend with a -6.2% CAGR.
other_variable_interest_entity_primary_beneficiary_maxim_00412e| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.30M | $22.70M | $22.40M | $20.50M | $21.10M | $21.10M | $21.00M | $20.50M | $20.50M | $20.20M | $19.70M |
| QoQ Change | — | -10.3% | -1.3% | -8.5% | +2.9% | +0.0% | -0.5% | -2.4% | +0.0% | -1.5% | -2.5% |
| YoY Change | — | — | — | — | -16.6% | -7.0% | -6.3% | +0.0% | -2.8% | -4.3% | -6.2% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Insurance | $23.70M | $194.80M | $196.80M | $23.00M | $23.00M | $22.90M | $31.90M | $447.20M |
| Total | — | — | — | — | — | — | — | — |